Clinical Trial Update: Safety and Efficacy Study of Switching From Epzicom to Truvada [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy study evaluating switching from Epzicom to Truvada in HIV infection completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2012-04-19